Oxaliplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Oxaliplatin Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on 06/29/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Package NDC
- 25021-233-20
- Dosage Form
- Injection
- Presentation
- Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)
- Initial Posting
- 06/29/2026
- Revised Date